My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 173

    1.

    Decrease in the glyceraldehyde derived advanced glycation end products in the sera of patients with Vogt-Koyanagi-Harada disease.

    Kitamura M, Kitaichi N, Takeuchi M, Kitamei H, Namba K, Yamagishi SI, Iwabuchi K, Onoé K, Ohno S.

    Br J Ophthalmol. 2005 Nov;89(11):1407-9.PMID: 16234440 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Chemokine profile in the cerebrospinal fluid and serum of Vogt-Koyanagi-Harada disease.

    Miyazawa I, Abe T, Narikawa K, Feng J, Misu T, Nakashima I, Fujimori J, Tamai M, Fujihara K, Itoyama Y.

    J Neuroimmunol. 2005 Jan;158(1-2):240-4.PMID: 15589059 [PubMed - indexed for MEDLINE]Related articles

    3.

    Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt-Koyanagi-Harada's disease.

    Uchio E, Matsumoto T, Tanaka SI, Ohno S.

    Clin Exp Rheumatol. 1999 Mar-Apr;17(2):179-84.PMID: 10342043 [PubMed - indexed for MEDLINE]Related articles

    4.

    Analysis of serum of patients with Alzheimer's disease for the level of advanced glycation end products.

    Leszek J, Malyszczak K, Bartys A, Staniszewska M, Gamian A.

    Am J Alzheimers Dis Other Demen. 2006 Oct-Nov;21(5):360-5.PMID: 17062556 [PubMed - indexed for MEDLINE]Related articles

    5.

    High incidence of glucose intolerance in Vogt-Koyanagi-Harada disease.

    Yawata N, Nakamura S, Kijima M, Ikai N, Kanai M, Sugita M, Ohno S.

    Br J Ophthalmol. 1999 Jan;83(1):39-42.PMID: 10209432 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Humoral immune response directed against LEDGF in patients with VKH.

    Yamada K, Senju S, Shinohara T, Nakatsura T, Murata Y, Ishihara M, Nakamura S, Ohno S, Negi A, Nishimura Y.

    Immunol Lett. 2001 Oct 1;78(3):161-8.PMID: 11578690 [PubMed - indexed for MEDLINE]Related articles

    7.

    Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.

    Tan KC, Shiu SW, Chow WS, Leng L, Bucala R, Betteridge DJ.

    Diabetologia. 2006 Nov;49(11):2756-62. Epub 2006 Sep 13.PMID: 16969649 [PubMed - indexed for MEDLINE]Related articles

    8.

    Leptin increases in Vogt-Koyanagi-Harada (VKH) disease and promotes cell proliferation and inflammatory cytokine secretion.

    Liu L, Yang P, He H, Lin X, Jiang L, Chi W, Zhao C, Zhou H.

    Br J Ophthalmol. 2008 Apr;92(4):557-61. Epub 2008 Feb 1.PMID: 18245271 [PubMed - indexed for MEDLINE]Related articles

    9.

    Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis.

    Hyogo H, Yamagishi S, Iwamoto K, Arihiro K, Takeuchi M, Sato T, Ochi H, Nonaka M, Nabeshima Y, Inoue M, Ishitobi T, Chayama K, Tazuma S.

    J Gastroenterol Hepatol. 2007 Jul;22(7):1112-9. Epub 2007 Jun 7.PMID: 17559366 [PubMed - indexed for MEDLINE]Related articles

    10.

    Serum levels of glucose-derived advanced glycation end products are associated with the severity of diabetic retinopathy in type 2 diabetic patients without renal dysfunction.

    Koga K, Yamagishi S, Okamoto T, Inagaki Y, Amano S, Takeuchi M, Makita Z.

    Int J Clin Pharmacol Res. 2002;22(1):13-7.PMID: 12395914 [PubMed - indexed for MEDLINE]Related articles

    11.

    Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.

    Chen L, Yang P, Zhou H, He H, Ren X, Chi W, Wang L, Kijlstra A.

    Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3475-82. Epub 2008 Apr 17.PMID: 18421089 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey.

    Tugal-Tutkun I, Ozyazgan Y, Akova YA, Sullu Y, Akyol N, Soylu M, Kazokoglu H.

    Int Ophthalmol. 2007 Apr-Jun;27(2-3):117-23. Epub 2006 Sep 7.PMID: 16957877 [PubMed - indexed for MEDLINE]Related articles

    13.

    Advanced glycation end products in nondiabetic patients with coronary artery disease.

    Kanauchi M, Tsujimoto N, Hashimoto T.

    Diabetes Care. 2001 Sep;24(9):1620-3.PMID: 11522709 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Products of advanced glycation in patients with type 2 diabetes and vascular disease.

    Turk Z, Sesto M, Skodlar J, Ferencak G, Pokupec R, Turk N, Stavljenić-Rukavina A.

    Ann Clin Biochem. 2003 Sep;40(Pt 5):552-9.PMID: 14503994 [PubMed - indexed for MEDLINE]Related articles

    15.

    Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.

    Yamagishi S, Nakamura K, Inoue H, Kikuchi S, Takeuchi M.

    Med Hypotheses. 2005;64(6):1205-7.PMID: 15823718 [PubMed - indexed for MEDLINE]Related articles

    16.

    Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease.

    Norose K, Yano A, Wang XC, Tokushima T, Umihira J, Seki A, Nohara M, Segawa K.

    Invest Ophthalmol Vis Sci. 1994 Jan;35(1):33-9.PMID: 8300361 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The spectrum of Vogt-Koyanagi-Harada disease in Tunisia, North Africa.

    Khairallah M, Zaouali S, Messaoud R, Chaabane S, Attia S, Ben Yahia S, Hmidi K.

    Int Ophthalmol. 2007 Apr-Jun;27(2-3):125-30. Epub 2007 Jan 4.PMID: 17203358 [PubMed - indexed for MEDLINE]Related articles

    18.

    IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease.

    Chi W, Yang P, Li B, Wu C, Jin H, Zhu X, Chen L, Zhou H, Huang X, Kijlstra A.

    J Allergy Clin Immunol. 2007 May;119(5):1218-24. Epub 2007 Mar 1.PMID: 17335887 [PubMed - indexed for MEDLINE]Related articles

    19.

    Prognostic factors for Vogt-Koyanagi-Harada disease.

    Sheu SJ, Kou HK, Chen JF.

    J Chin Med Assoc. 2003 Mar;66(3):148-54.PMID: 12779034 [PubMed - indexed for MEDLINE]Related articles

    20.

    Vogt-koyanagi-harada disease with onset in elderly patients aged 68 to 89 years.

    Yamamoto Y, Fukushima A, Nishino K, Koura Y, Komatsu T, Ueno H.

    Jpn J Ophthalmol. 2007 Jan-Feb;51(1):60-3. Epub 2007 Feb 9.PMID: 17295144 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity